Pink Sheet: Informa Pharma Intelligence – January 21, 2020

Nancy Bradish Myers is quoted by the Pink Sheet explaining the potential value of nominating a former Center Director to be a Commissioner. It may be a strong signal that the Biden Administration will allow the FDA to follow the science.

Read the full article: Woodcock Faces Maze Of Rules To Become Commissioner Nominee here